Trials / Completed
CompletedNCT02404922
Multiple Ascending Dose Study in Healthy Volunteers
A Phase I Single Center, Double-Blind, Placebo-Controlled, Multiple Dose-Ascending Study to Evaluate the Pharmacokinetics and Tolerability of CTP-730 Immediate Release at Steady State in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Concert Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This study will assess in healthy male and female subjects the safety, tolerability and pharmacokinetics (PK) profiles of Immediate Release CTP-730 at steady state following 7 days of dosing. Three doses of Immediate Release (IR) CTP-730 capsules will be studied.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CTP-730 | |
| DRUG | Placebo for CTP-730 |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2015-04-01
- Last updated
- 2016-02-05
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT02404922. Inclusion in this directory is not an endorsement.